| Tooele Foot & Ankle Clinic, Inc. | |
|
2356 N 400 E, Ste 104, Tooele, UT 84074-3409 | |
| (435) 882-0711 | |
| (435) 882-1778 |
| Full Name | Tooele Foot & Ankle Clinic, Inc. |
|---|---|
| Type | Facility |
| Speciality | Podiatrist - Foot & Ankle Surgery |
| Location | 2356 N 400 E, Tooele, Utah |
| Accepts Medicare Assignments | Medicare enrolled and accepts medicare insurance. Providers at this facility may prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1255509154 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 213ES0103X | Podiatrist - Foot & Ankle Surgery | 103966-0501 (* (Not Available)) | Primary |
| Provider Name | Kim A Halladay |
|---|---|
| Provider Type | Practitioner - Podiatry |
| Provider Identifiers | NPI Number: 1902809528 PECOS PAC ID: 5193730786 Enrollment ID: I20060220000073 |
News Archive
Research led by Sophie Meakin of the London School of Hygiene & Tropical Medicine in the United Kingdom suggests ensemble forecasts — a method combining multiple models to predict COVID-19 cases — may be more accurate in estimating COVID-19 hospital admissions in local areas.
Will adding fiber to my diet bring relief? Are dairy products really off limits? Is there a way to actually diagnose what I have, or is it all in my head?
Hovione and Dickstein Shapiro LLP are pleased to announce that the U.S. Patent and Trademark's Board of Patent Appeals and Interferences has reconfirmed Hovione's patent claims to a method of making flumethasone and its 17-carboxyl androsten analogue, two key intermediates on the synthesis of fluticasone, an important corticosteroid used in asthma medications, reversing a rejection by the reexamination examiner.
A paper published in the open-access journal Viruses, reports on a study investigating long-term changes to soluble inflammatory factors and cellular immune phenotype and function in 22 survivors of mild SARS-CoV-2 infection. The observations were then compared to 11 individuals who had recovered from other mild respiratory infections.
Nuvo Research Inc., a Canadian drug development company focused on the research and development of drug products that are delivered to and through the skin using its topical and transdermal drug delivery technologies, and on the development of its immune modulating drug candidate WF10, today announced a co-operative drug development project with the Fraunhofer Institute for Cell Therapy and Immunology IZI in Leipzig, Germany for the preclinical and clinical development of WF10 as a potential treatment for Allergic Rhinitis.
› Verified 1 days ago
| Provider Name | David George Mckenzie |
|---|---|
| Provider Type | Practitioner - Podiatry |
| Provider Identifiers | NPI Number: 1245541937 PECOS PAC ID: 5092940593 Enrollment ID: I20131126000491 |
News Archive
Research led by Sophie Meakin of the London School of Hygiene & Tropical Medicine in the United Kingdom suggests ensemble forecasts — a method combining multiple models to predict COVID-19 cases — may be more accurate in estimating COVID-19 hospital admissions in local areas.
Will adding fiber to my diet bring relief? Are dairy products really off limits? Is there a way to actually diagnose what I have, or is it all in my head?
Hovione and Dickstein Shapiro LLP are pleased to announce that the U.S. Patent and Trademark's Board of Patent Appeals and Interferences has reconfirmed Hovione's patent claims to a method of making flumethasone and its 17-carboxyl androsten analogue, two key intermediates on the synthesis of fluticasone, an important corticosteroid used in asthma medications, reversing a rejection by the reexamination examiner.
A paper published in the open-access journal Viruses, reports on a study investigating long-term changes to soluble inflammatory factors and cellular immune phenotype and function in 22 survivors of mild SARS-CoV-2 infection. The observations were then compared to 11 individuals who had recovered from other mild respiratory infections.
Nuvo Research Inc., a Canadian drug development company focused on the research and development of drug products that are delivered to and through the skin using its topical and transdermal drug delivery technologies, and on the development of its immune modulating drug candidate WF10, today announced a co-operative drug development project with the Fraunhofer Institute for Cell Therapy and Immunology IZI in Leipzig, Germany for the preclinical and clinical development of WF10 as a potential treatment for Allergic Rhinitis.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Tooele Foot & Ankle Clinic, Inc. 2356 N 400 E, Ste 104, Tooele, UT 84074-3409 Ph: (435) 882-0711 | Tooele Foot & Ankle Clinic, Inc. 2356 N 400 E, Ste 104, Tooele, UT 84074-3409 Ph: (435) 882-0711 |
News Archive
Research led by Sophie Meakin of the London School of Hygiene & Tropical Medicine in the United Kingdom suggests ensemble forecasts — a method combining multiple models to predict COVID-19 cases — may be more accurate in estimating COVID-19 hospital admissions in local areas.
Will adding fiber to my diet bring relief? Are dairy products really off limits? Is there a way to actually diagnose what I have, or is it all in my head?
Hovione and Dickstein Shapiro LLP are pleased to announce that the U.S. Patent and Trademark's Board of Patent Appeals and Interferences has reconfirmed Hovione's patent claims to a method of making flumethasone and its 17-carboxyl androsten analogue, two key intermediates on the synthesis of fluticasone, an important corticosteroid used in asthma medications, reversing a rejection by the reexamination examiner.
A paper published in the open-access journal Viruses, reports on a study investigating long-term changes to soluble inflammatory factors and cellular immune phenotype and function in 22 survivors of mild SARS-CoV-2 infection. The observations were then compared to 11 individuals who had recovered from other mild respiratory infections.
Nuvo Research Inc., a Canadian drug development company focused on the research and development of drug products that are delivered to and through the skin using its topical and transdermal drug delivery technologies, and on the development of its immune modulating drug candidate WF10, today announced a co-operative drug development project with the Fraunhofer Institute for Cell Therapy and Immunology IZI in Leipzig, Germany for the preclinical and clinical development of WF10 as a potential treatment for Allergic Rhinitis.
› Verified 1 days ago
Dr. David George Mckenzie Ii, D.P.M. Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 2376 N 400 E Ste 204, Tooele, UT 84074 Phone: 801-582-1565 | |
Dr. Derek Scott Anselmo, DPM Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 2376 N 400 E Ste 204, Tooele, UT 84074 Phone: 610-983-1000 | |
Kim A. Halladay, D.P.M. Podiatrist Medicare: Medicare Enrolled Practice Location: 2356 N 400 E, Ste 104, Tooele, UT 84074 Phone: 435-882-0711 Fax: 435-882-1778 |